Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …

News
astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …

News
az

AstraZeneca’s Brilinta reduces the rate of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack

July 16, 2020
Business Services AZ, AstraZeneca, drug trials

AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with …

News
european_commission_web

European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer

July 8, 2020
Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …

News
shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

June 25, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …

News
astrazeneca_sign_sky

AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients

June 8, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.

News
astrazeneca_building_white

AstraZeneca announces new partnerships to deliver two billion COVID-19 vaccine doses, with focus on developing countries

June 5, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, Vaccine, coronavirus

As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …

News
lynparza

Lynparza secures CHMP recommendation in first-line BRCA-mutated metastatic pancreatic cancer

June 1, 2020
Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza

Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has just secured recommendation for approval from the European Medicines …

News
astrazeneca_sign_sky

AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine

May 19, 2020
Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma

AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …

News
fda2outsideweb

Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer

May 11, 2020
Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer

Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …

News
fda2outsideweb

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020
Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …

News
512px-oxford_university_colleges-all_souls1

AstraZeneca joins forces with University of Oxford to develop and manufacture potential coronavirus vaccine

April 30, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, University of Oxford, coronavirus, pharma

A “landmark” partnership has been struck between AstraZeneca and the University of Oxford in the ongoing battle against COVID-19, with …

News
astrazeneca_building_white

AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch

April 14, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma

As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …

News
shutterstock_138095450

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020
Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …

News
astrazeneca_building_white

FDA immunotherapy first with the approval of AZ’s Imfinzi in first-line extensive-stage small cell lung cancer

March 30, 2020
Sales and Marketing AstraZeneca, Cancer, FDA, Imfinzi, lung cancer, pharma

AstraZeneca has seized FDA approval for its immune checkpoint inhibitor Imfinzi (durvalumab) in the first-line treatment of extensive-stage small cell …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025